Elevated Serum Nardilysin Is Inversely Associated with Cardiovascular Disease in Kidney Transplant Recipients
Kidney and Blood Pressure Research · 21.05.2026 · 51 (1) · 518-529
DOI: 10.1159/000552202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney and Blood Pressure Research, online erschienen am 21.05.2026. Verfasst von Anna Sączek und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Transplantology, Jagiellonian University Medical College, Kraków, Poland. Hauptthemen laut MEDLINE: Kidney Transplantation, Cardiovascular Diseases. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Kidney transplant recipients (KTRs) suffer from enhanced cardiovascular (CV) and metabolic burden due to interplay between pro-inflammatory and metabolic risk factors. Nardilysin (NRDc) and mitochondrial open reading frame of 12S rRNA-c (MOTS-c) are circulating peptides that represent candidate markers of cardiometabolic pathobiology, though their relevance in KTRs is unknown.
Methods
We measured serum NRDc and MOTS-c concentrations in an observational cohort of 150 patients (118 KTRs and aged-matched controls – 32 patients) using commercial ELISA kits. KTRs were followed for a median of 29.2 (25.3–31.9) months. Relationships with CV and metabolic parameters were assessed using Pearson’s correlation and penalized logistic regression. Renal allograft loss with all-cause mortality as competing event was examined using Fine-Gray regression.
Results
Median serum NRDc (1.91 vs. 0.42 ng/mL, p < 0.001) and MOTS-c (178 vs. 142 ng/mL, p = 0.014) were significantly higher in KTRs, as compared with controls. NRDc showed a weak positive linear relationship with BMI (r = 0.21, p = 0.02). After adjusting for age and sex, higher standardized ln-NRDc was independently associated with lower odds of prevalent CV disease (OR 0.59, 95% CI: 0.34–0.97, p = 0.04). This CV disease association was stable after further adjustment for hsIL-6. We did not observe significant associations for MOTS-c and cardiometabolic features. In competing risk analysis, MOTS-c showed a consistent but nonsignificant trend toward lower risk of allograft loss (adj. sHR 0.50, 95% CI: 0.22–1.10, p = 0.08), while NRDc was not associated with allograft loss. Both serum NRDc and MOTS-c markers were not associated with all-cause mortality or follow-up eGFR decline.
Conclusions
Elevated circulating serum NRDc and MOTS-c levels in KTRs may reflect altered metabolic and inflammatory pathways. The inverse association between NRDc and prevalent CV disease warrants further investigation in longitudinal studies with incident CV events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Transplantology, Jagiellonian University Medical College, Kraków, Poland.
- Department of Dermatology, Jagiellonian University Medical College, Kraków, Poland.
- Department of Nephrology, Dialysis and Internal Medicine, Warsaw Medical University, Warsaw, Poland.
- 2nd Department of Nephrology, Hypertension and Internal Medicine with Dialysis Unit, Medical University of Bialystok, Białystok, Poland.
- The Academy of Applied Medical and Social Sciences, Elbląg, Poland.
- Department of Cardiology, Lipidology and Internal Medicine with Cardiac Intensive Care Unit, Medical University of Bialystok, Białystok, Poland.
Zitieren
APA
Sączek, A., Batko, K., Banaszkiewicz, M., Małyszko, J., Koc-Żórawska, E., Żórawski, M., Niezabitowska, K., Sobczyńska, K., Miarka, P., Bętkowska-Prokop, A., Krzanowska, K., & Krzanowski, M. (2026). Elevated Serum Nardilysin Is Inversely Associated with Cardiovascular Disease in Kidney Transplant Recipients. Kidney and Blood Pressure Research, 51(1), 518-529. https://doi.org/10.1159/000552202
Vancouver
Sączek A, Batko K, Banaszkiewicz M, Małyszko J, Koc-Żórawska E, Żórawski M, et al. Elevated Serum Nardilysin Is Inversely Associated with Cardiovascular Disease in Kidney Transplant Recipients. Kidney and Blood Pressure Research. 2026;51(1):518-529. doi:10.1159/000552202
BibTeX
@article{Sczek2026,
author = {Sączek, Anna and Batko, Krzysztof and Banaszkiewicz, Małgorzata and Małyszko, Jolanta and Koc-Żórawska, Ewa and Żórawski, Marcin and Niezabitowska, Karolina and Sobczyńska, Katarzyna and Miarka, Przemysław and Bętkowska-Prokop, Alina and Krzanowska, Katarzyna and Krzanowski, Marcin},
title = {Elevated Serum Nardilysin Is Inversely Associated with Cardiovascular Disease in Kidney Transplant Recipients},
journal = {Kidney and Blood Pressure Research},
year = {2026},
volume = {51},
number = {1},
pages = {518--529},
doi = {10.1159/000552202}
}
EUVIMED